211 related articles for article (PubMed ID: 29223168)
1. Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report.
Nonaka H; Onishi H; Ozaki M; Kuriyama K; Komiyama T; Saito R
J Med Case Rep; 2017 Dec; 11(1):343. PubMed ID: 29223168
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiotherapy of targets in the lung and liver.
Wulf J; Hädinger U; Oppitz U; Thiele W; Ness-Dourdoumas R; Flentje M
Strahlenther Onkol; 2001 Dec; 177(12):645-55. PubMed ID: 11789403
[TBL] [Abstract][Full Text] [Related]
3. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
5. Pulsed reduced dose-rate radiotherapy as re-irradiation for brain metastasis in a patient with lung squamous-celled carcinoma.
Li GH; Liu Y; Tang JL; Zhang D; Zhou P; Yang DQ; Ma CK
Jpn J Clin Oncol; 2012 Sep; 42(9):856-60. PubMed ID: 22701036
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
7. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
[TBL] [Abstract][Full Text] [Related]
8. Re-Irradiation of Locoregional NSCLC Recurrence Using Robotic Stereotactic Body Radiotherapy.
Ceylan C; Hamacı A; Ayata H; Berberoglu K; Kılıç A; Güden M; Engin K
Oncol Res Treat; 2017; 40(4):207-214. PubMed ID: 28324876
[TBL] [Abstract][Full Text] [Related]
9. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
10. Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell Carcinoma.
Quan K; Xu KM; Zhang Y; Clump DA; Flickinger JC; Lalonde R; Burton SA; Heron DE
Semin Radiat Oncol; 2016 Apr; 26(2):112-9. PubMed ID: 27000507
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.
Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto T; Sakamoto M; Mitsumori M; Shibuya K; Araki N; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1427-31. PubMed ID: 16169670
[TBL] [Abstract][Full Text] [Related]
12. Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
Nishimura S; Takeda A; Sanuki N; Ishikura S; Oku Y; Aoki Y; Kunieda E; Shigematsu N
J Thorac Oncol; 2014 Sep; 9(9):1370-6. PubMed ID: 25122433
[TBL] [Abstract][Full Text] [Related]
13. Salvage stereotactic re-irradiation with CyberKnife for locally recurrent head and neck cancer: a single center experience.
Bonomo P; Cipressi S; Iermano C; Bonucci I; Masi L; Doro R; Favuzza V; Paiar F; Simontacchi G; Meattini I; Greto D; Agresti B; Livi L; Biti G
Tumori; 2014; 100(3):278-83. PubMed ID: 25076238
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Effects Between Central and Peripheral Stage I Lung Cancer Using Image-Guided Stereotactic Body Radiotherapy via Helical Tomotherapy.
He J; Huang Y; Shi S; Hu Y; Zeng Z
Technol Cancer Res Treat; 2015 Dec; 14(6):701-7. PubMed ID: 25911646
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy for adenoid cystic carcinoma metastatic to the lung: a case report.
Kobayashi D; Abe T; Saitoh JI; Oike T; Sato H; Musha A; Mizukami T; Shimizu T; Nakano T; Ohno T
J Med Case Rep; 2021 Apr; 15(1):156. PubMed ID: 33838695
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.
Kanemoto A; Okumura T; Ishikawa H; Mizumoto M; Oshiro Y; Kurishima K; Homma S; Hashimoto T; Ohkawa A; Numajiri H; Ohno T; Moritake T; Tsuboi K; Sakae T; Sakurai H
Clin Lung Cancer; 2014 Mar; 15(2):e7-12. PubMed ID: 24365049
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer.
Matsuo Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818798633. PubMed ID: 30198413
[TBL] [Abstract][Full Text] [Related]
18. Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer.
Kim H; Ahn YC; Park HC; Lim DH; Nam H
J Thorac Oncol; 2010 Apr; 5(4):526-32. PubMed ID: 20104193
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.
Heron DE; Ferris RL; Karamouzis M; Andrade RS; Deeb EL; Burton S; Gooding WE; Branstetter BF; Mountz JM; Johnson JT; Argiris A; Grandis JR; Lai SY
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1493-500. PubMed ID: 19464819
[TBL] [Abstract][Full Text] [Related]
20. Pembrolizumab combined with stereotactic body radiotherapy in a patient with human immunodeficiency virus and advanced non-small cell lung cancer: a case report.
Li D; He C; Xia Y; Du Y; Zhang J
J Med Case Rep; 2018 Apr; 12(1):104. PubMed ID: 29681240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
